MERCK & CO, INC. for MERCK & CO INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicaid, Medicare, Medicare Part B, Medicaid Rebate Cap, 340B reforms Medicare Part D, Drug Pricing and Center for Medicare & Medicaid Innovation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| ROBERT FILIPPONE | — |
| COREY MALMGREN New | — |
| BRADLEY ALLEN ROSSIN | — |
| ELIZABETH SCHWARTZ | — |
Consumer Issues/Safety/Products CSP
Direct to Consumer Advertising.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
Copyright/Patent/Trademark CPT
Intellectual Property, Intellectual Property Rebate Cap, Patents, US-Mexico-Canada Agreement and US-China trade
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FILIPPONE | — |
| COREY MALMGREN | — |
| ELIZABETH SCHWARTZ | — |
Taxation/Internal Revenue Code TAX
Tax Reform, Generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRADLEY ALLEN ROSSIN | — |
Agriculture AGR
Funding levels for the Center for Veterinary Biologics in the Animal and Plant Health Inspection Service at the United State Department of Agriculture.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRADLEY ALLEN ROSSIN | — |
Health Issues HCR
340B Reforms, Drug pricing, Anti-microbial Resistance, AMRDrug Pricing; General Pharmaceutical issues transparency, formulary design, prescription drug coverage, Patent Thickets, W&M Markup Transparency, Biosimiliars, Diabetes, Cost and Value of Medicines, Maternal Health and Mortality, Women's Reproductive, Research and Development, Vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIN DARLING | — |
| ROBERT FILIPPONE | — |
| COREY MALMGREN | — |
| BRADLEY ALLEN ROSSIN | — |
| ELIZABETH SCHWARTZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.